Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 06/26/24
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataCNBC • 06/26/24
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory DiseasesBusiness Wire • 06/26/24
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteriaPRNewsWire • 06/25/24
From Sci-Fi Dream to Market Maze: Eli Lilly's Weight-Loss Medication Faces HurdlesGuruFocus • 06/25/24
Medical-device makers ResMed and Inspire slump after Lilly's Zepbound trial shows benefits for sleep apneaMarket Watch • 06/24/24
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to KnowZacks Investment Research • 06/24/24
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — AgainInvestors Business Daily • 06/24/24
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly saysReuters • 06/21/24